dddmag.com
Drug Discovery & Development  

Drug Development
Features
News
Products






SITE SPONSORS 










Advertise with Us
 

Browse Products:


Managing the Research Laboratory for Optimum Decision Making
hiwWhile there are many challenges to running an efficient research laboratory, data management is one of the most critical issues facing scientists within drug discovery and development.  continue
Kim Shah, Vice President, Marketing and Business Development; Thermo Fisher Scientific, Pittsburgh, Pa.


Transfer Plasmid
Oxford Expression Technologies, a specialist provider of baculovirus-based protein expression solutions, launches pOET3, a novel baculovirus transfer plasmid for improved expression of glycosylated, secreted, and membrane-targeted proteins.  continue



Electronic Document Management
xdocsRegulatory compliance experts GxPi announce the availability of its leading Electronic Document Management System (eDMS) x-docs as a hosted software service.  continue



Spectroscopy Software
GRAMSThermo Fisher Scientific Inc. announced the latest release in its GRAMS Suite of spectroscopy software, an industry standard solution for visualizing, processing, reporting and managing spectroscopy data.  continue



Analyte Detector
dortonAvailable from Dorton Analytical the ultra-sensitive, universal Nano Quantity Analyte Detector (NQAD) presents a major advancement in high performance liquid chromatography detection capability.  continue



Diffuse Reflectance Probe
Axiom Analytical, Inc. has announced its fiber-optic coupled FDR-805 Diffuse Reflectance Probe that operates in the near-infrared (near-IR) and visible spectral regions.  continue



Reverse Cholesterol Transport Oral Small-Molecule - RVX-208
Biotechnology company, Resverlogix Corp. in Calgary, Canada, is developing a first-in-class small-molecule oral drug, RVX-208, to clear plaque out of arteries, something that leading drugs in the $35 billion cholesterol market have so far failed to do.  continue
Jan O. Johansson, MD, PhD, Resverlogix Senior Vice President of Medical Affairs, F. Allan Gordon, MD, PhD, Resverlogix, Senior Vice President of Clinical Development


Large Molecules Cross The Transdermal Barrier
hiw-5Until recently, transdermal patches were only useful for small molecule therapies because of the inability of larger molecules (such as proteins) to passively cross through the outer skin layers.  continue
Christof Böhler, CEO, Pantec Biosolutions AG, Ruggell, Liechtenstein


Flow Cytometry Reagents
BD Biosciences, a segment of BD (Becton, Dickinson and Company), has launched the BD Kaleidoscope reagent and dye expansion program—marked by the release of nearly 200 new fluorochrome-conjugated antibodies for flow cytometry to help meet today’s life science research needs.  continue



Petri Dish Filler
integraINTEGRA Biosciences has released an updated MEDIAJET automated Petri dish filler.  continue





Most Popular